Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: AgFinder who wrote (2597)	5/3/1999 4:34:00 PM
From: AJAG	Read Replies (1) \| Respond to of 10280

Does anybody think that Sepracor is only worth one sixteenth of Amgen's market value? I am really tempted to short Amgen and use the proceeds to buy more SEPR.

To: AgFinder who wrote (2597)	5/3/1999 4:34:00 PM
From: BMcV	Read Replies (1) \| Respond to of 10280

I don't know, I don't use stops. But my naive feeling is that people who bought the last dip may have put stops in at round numbers about 10% below their price, so that might explain the heavy action around 80, 79 and 78 that was apparent on quote.com. But you might be right too that the stops were for shorts, only that the price fell right through, suggesting they were sales. Take a look at quote.com -- there are two form T trades at 80 7/16, one for 25,000 shares and the other for 31,500 shares, time stamps 16:06:36 and 16:05:19 respectively. quote.com